190 related articles for article (PubMed ID: 10715265)
1. The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system : relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes.
Wollert KC; Heineke J; Westermann J; Lüdde M; Fiedler B; Zierhut W; Laurent D; Bauer MK; Schulze-Osthoff K; Drexler H
Circulation; 2000 Mar; 101(10):1172-8. PubMed ID: 10715265
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701.
Stephanou A; Scarabelli TM; Brar BK; Nakanishi Y; Matsumura M; Knight RA; Latchman DS
J Biol Chem; 2001 Jul; 276(30):28340-7. PubMed ID: 11309387
[TBL] [Abstract][Full Text] [Related]
3. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
Afford SC; Ahmed-Choudhury J; Randhawa S; Russell C; Youster J; Crosby HA; Eliopoulos A; Hubscher SG; Young LS; Adams DH
FASEB J; 2001 Nov; 15(13):2345-54. PubMed ID: 11689460
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL.
Peng Y; Gallagher SF; Haines K; Baksh K; Murr MM
J Surg Res; 2006 Jan; 130(1):58-65. PubMed ID: 16154149
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappaB and tumor necrosis factor-alpha in macrophages.
Lu B; Wang L; Medan D; Toledo D; Huang C; Chen F; Shi X; Rojanasakul Y
Am J Physiol Cell Physiol; 2002 Sep; 283(3):C831-8. PubMed ID: 12176740
[TBL] [Abstract][Full Text] [Related]
6. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.
Kasibhatla S; Brunner T; Genestier L; Echeverri F; Mahboubi A; Green DR
Mol Cell; 1998 Mar; 1(4):543-51. PubMed ID: 9660938
[TBL] [Abstract][Full Text] [Related]
7. Regulation of FasL by NF-kappaB and AP-1 in Fas-dependent thymineless death of human colon carcinoma cells.
Harwood FG; Kasibhatla S; Petak I; Vernes R; Green DR; Houghton JA
J Biol Chem; 2000 Apr; 275(14):10023-9. PubMed ID: 10744679
[TBL] [Abstract][Full Text] [Related]
8. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload.
Badorff C; Ruetten H; Mueller S; Stahmer M; Gehring D; Jung F; Ihling C; Zeiher AM; Dimmeler S
J Clin Invest; 2002 Feb; 109(3):373-81. PubMed ID: 11827997
[TBL] [Abstract][Full Text] [Related]
9. NF-kappa B-dependent Fas ligand expression.
Hsu SC; Gavrilin MA; Lee HH; Wu CC; Han SH; Lai MZ
Eur J Immunol; 1999 Sep; 29(9):2948-56. PubMed ID: 10508269
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of anti-apoptotic action of dipfluzine on neuronal damage of the rat hippocampal CA1 region subjected to transient forebrain ischemia.
Zhang YJ; Guo Y; Jia QZ; Wang YL; Zhang HL
Yao Xue Xue Bao; 2005 Feb; 40(2):97-104. PubMed ID: 15875662
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines.
Rajashekhar G; Loganath A; Roy AC; Mongelli JM
Gynecol Oncol; 2003 Oct; 91(1):101-11. PubMed ID: 14529668
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation.
Contini P; Ghio M; Merlo A; Poggi A; Indiveri F; Puppo F
J Immunol; 2005 Dec; 175(11):7244-54. PubMed ID: 16301629
[TBL] [Abstract][Full Text] [Related]
13. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
[TBL] [Abstract][Full Text] [Related]
14. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.
Kataoka T; Budd RC; Holler N; Thome M; Martinon F; Irmler M; Burns K; Hahne M; Kennedy N; Kovacsovics M; Tschopp J
Curr Biol; 2000 Jun; 10(11):640-8. PubMed ID: 10837247
[TBL] [Abstract][Full Text] [Related]
15. Death the Fas way: regulation and pathophysiology of CD95 and its ligand.
Sharma K; Wang RX; Zhang LY; Yin DL; Luo XY; Solomon JC; Jiang RF; Markos K; Davidson W; Scott DW; Shi YF
Pharmacol Ther; 2000 Dec; 88(3):333-47. PubMed ID: 11337030
[TBL] [Abstract][Full Text] [Related]
16. Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.
Villunger A; Ghaffari-Tabrizi N; Tinhofer I; Krumböck N; Bauer B; Schneider T; Kasibhatla S; Greil R; Baier-Bitterlich G; Uberall F; Green DR; Baier G
Eur J Immunol; 1999 Nov; 29(11):3549-61. PubMed ID: 10556809
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.
Park H; Jung YK; Park OJ; Lee YJ; Choi JY; Choi Y
J Immunol; 2005 Dec; 175(11):7193-201. PubMed ID: 16301623
[TBL] [Abstract][Full Text] [Related]
18. Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas: correlation with the prognostic factors.
Kim YS; Kim KH; Choi JA; Lee JH; Kim HK; Won NH; Kim I
Arch Pathol Lab Med; 2000 May; 124(5):687-93. PubMed ID: 10782148
[TBL] [Abstract][Full Text] [Related]
19. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
20. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.
Brunner T; Yoo NJ; LaFace D; Ware CF; Green DR
Int Immunol; 1996 Jul; 8(7):1017-26. PubMed ID: 8757947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
